Canertinib 2HCl
99%
- Product Code: 110472
CAS:
289499-45-2
| Molecular Weight: | 558.86 g./mol | Molecular Formula: | C₂₄H₂₇Cl₃FN₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09954112 | |
| Melting Point: | 188-190℃ | Boiling Point: | 691℃ at 760 mmHg |
| Density: | 1.355g/ml | Storage Condition: | -20℃ |
Product Description:
Canertinib 2HCl is primarily used in cancer research and treatment, specifically targeting certain types of cancers by inhibiting specific enzymes involved in tumor growth. It is often studied for its potential in treating cancers such as breast cancer, lung cancer, and glioblastoma, where it helps to block the activity of epidermal growth factor receptors (EGFRs) that promote cancer cell proliferation. Researchers utilize this compound to explore its efficacy in combination therapies, aiming to enhance the effectiveness of existing cancer treatments. Additionally, it serves as a valuable tool in preclinical studies to better understand the mechanisms of EGFR signaling pathways and their role in cancer progression.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $145.66 |
+
-
|
| 0.050 | 10-20 days | $384.23 |
+
-
|
| 0.250 | 10-20 days | $1,104.97 |
+
-
|
| 1.000 | 10-20 days | $2,129.58 |
+
-
|
Canertinib 2HCl
Canertinib 2HCl is primarily used in cancer research and treatment, specifically targeting certain types of cancers by inhibiting specific enzymes involved in tumor growth. It is often studied for its potential in treating cancers such as breast cancer, lung cancer, and glioblastoma, where it helps to block the activity of epidermal growth factor receptors (EGFRs) that promote cancer cell proliferation. Researchers utilize this compound to explore its efficacy in combination therapies, aiming to enhance the effectiveness of existing cancer treatments. Additionally, it serves as a valuable tool in preclinical studies to better understand the mechanisms of EGFR signaling pathways and their role in cancer progression.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :